Implications of Paneth cell dysfunction on gastrointestinal health and disease. Issue 6 (24th November 2022)

• Record Type: Journal Article
• Authors: Lee, Vivian H.; Gulati, Ajay S.
• Is Part Of: Current opinion in gastroenterology. Volume 38:Issue 6(2022)
• Page Start: 535
• Page End: 540
• Publication Date: 2022-11-24
• Subjects: antimicrobial peptide -- Crohn's disease -- Paneth cell; Gastroenterology -- Periodicals; 616.33
• DOI: 10.1097/MOG.0000000000000887
• Languages: English
• ISSNs: 0267-1379

Abstract

Abstract : Purpose of review: Paneth cells are specialized, secretory epithelial cells located in the small intestine. Although their existence was first described in 1872, their precise role in the gut remained unclear for over a century. Over the past few decades, elegant studies have shown Paneth cells play a key role enhancing gut barrier function, as niche cells for the intestinal stem cell compartment and via secreting antimicrobial peptides to establish an antimicrobial barrier at the epithelial surface. This review describes what is known about Paneth cell biology from human and animal studies with a focus on their putative role in clinical gastrointestinal disease. Recent findings: Recent work has demonstrated important associations of dysfunctional Paneth cells with several gastrointestinal disorders. These include Crohn's disease, enteric infections, graft-versus-host disease, necrotizing enterocolitis, and environmental enteric dysfunction. Ongoing studies are examining precisely how Paneth cell biology is altered in these various disease states. Summary: By understanding the mechanisms of Paneth cell regulation – and how these processes go awry in specific gastrointestinal diseases – we set the stage for using Paneth cells as biomarkers for disease progression and developing novel therapeutics that augment Paneth cell function to treat a spectrum of gastrointestinal disorders.